Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;46(3):648-655.
doi: 10.1007/s11096-023-01691-w. Epub 2024 Feb 14.

A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United States

Michelle T Martin  1   2 , Aileen N Pham  3 , Jessica S Wagner  3
Affiliations

A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United States

Michelle T Martin et al. Int J Clin Pharm. 2024 Jun.

Abstract

Background: The Viral Hepatitis National Strategic Plan emphasizes the importance of a collaborative provider workforce trained in hepatitis prevention and treatment to eliminate viral hepatitis in the United States by 2030. Although pharmacists play a key role in hepatitis management, literature lacks documentation of the amount of viral hepatitis education provided to pharmacy students.

Aim: Our study goal was to describe viral hepatitis education provided at United States pharmacy schools.

Method: In this cross-sectional survey study, investigators developed a 19-item Qualtrics questionnaire, sent questionnaire links to curricula content experts at 140 accredited pharmacy colleges/schools in May-June 2022, and allotted 28 days for completion. Questions assessed the viral hepatitis instruction provided to students and hepatitis instructors' training/experience. We used descriptive statistics for analysis.

Results: Forty-eight pharmacy institutions across 29 states/territories responded; 44% had 50-99 students/class, and 58% used lecture and discussion to provide required hepatitis education. Students received more lecture (average = 3.4 h, range 0.8-1.6 h/hepatitis topic) than discussion (average = 1.7 h, range 0.6-0.9 h/hepatitis topic), with the most time spent on hepatitis C, followed by hepatitis B virus. Respondents reported 93% of their instructors had post-graduate training/certifications and 67% worked in clinical settings with hepatitis patients.

Conclusion: Survey results demonstrate variability in hepatitis education across United States pharmacy curricula. Data offer stakeholders in hepatitis elimination efforts knowledge about the viral hepatitis education provided to Doctor of Pharmacy students. Future directions include consideration of implementation of minimum hepatitis education standards to further support work toward national hepatitis elimination.

Keywords: Curriculum; Hepatitis C virus (HCV); Hepatitis B virus (HBV); Pharmacy education; Pharmacy school.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. World Health Organization Website. Available at https://www.who.int/publications/i/item/WHO-HIV-2016.06 . Accessed 15 July 2023.
    1. American Association for the Study of Liver Diseases. Call-to-Action to Advance Progress Towards Viral Hepatitis Elimination: A Focus on Simplified Approaches to HCV Testing and Cure. Available at. https://www.aasld.org/aasld-hepatitis-elimination-efforts-0 Accessed 15 July 2023.
    1. U.S. Department of Health and Human Services. Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021–2025). Available at https://www.hhs.gov/hepatitis/viral-hepatitis-national-strategic-plan/na... . Accessed 15 July 2023.
    1. World Health Organization. Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection. World Health Organization Website. Published June 24, 2022. Available at https://www.who.int/publications/i/item/9789240052697 . Accessed 15 July 2023.
    1. Deming P, Martin MT, Chan J, et al. Therapeutic advances in HCV genotype 1 infection: insights from the society of infectious diseases pharmacists. Pharmacotherapy. 2016;36(2):203–17. https://doi.org/10.1002/phar.1700 . - DOI - PubMed

LinkOut - more resources